Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by Lipid Therapeutics GmbH.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
Lipid Therapeutics GmbH Identifier:
First received: November 10, 2009
Last updated: November 15, 2011
Last verified: August 2010
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: February 2012
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):